Multiple sclerosis normal-appearing white matter: Pathology-imaging correlations

Annals of Neurology

Volumn 70, Issue 5, 2011, Pages 764-773

  Moll, Natalia M ^a,d   Rietsch, Anna M ^a   Thomas, Smitha ^a   Ransohoff, Amy J ^a   Lee, Jar Chi ^b   Fox, Robert ^c   Chang, Ansi ^a   Ransohoff, Richard M ^a,c   Fisher, Elizabeth ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Cleveland Clinic Lerner Research Institute ^*  (United States)

^c NEUROLOGICAL INSTITUTE   (United States)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN;

ADULT; AGED; ARTICLE; ASTROCYTE; BLOOD VESSEL; BRAIN TISSUE; CASE REPORT; DIFFUSION TENSOR IMAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MICROGLIA; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER;

ADULT; ASTROCYTES; AXONS; BIOLOGICAL MARKERS; BLOOD PROTEINS; BLOOD VESSELS; BRAIN; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MALE; MICROGLIA; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; POSTMORTEM CHANGES;

EID: 83255193056     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22521     Document Type: Article

References (48)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG,. Multiple sclerosis [review]. N Engl J Med 2000; 343: 938-952.
2. Kutzelnigg A, Lassmann H,. Cortical lesions and brain atrophy in MS [review]. J Neurol Sci 2005; 233: 55-59.
3. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128 (pt 11): 2705-2712.
4. Frohman EM, Racke MK, Raine CS,. Multiple sclerosis - the plaque and its pathogenesis [review]. N Engl J Med 2006; 354: 942-955.
5. Ludwin SK,. The pathogenesis of multiple sclerosis: relating human pathology to experimental studies [review]. J Neuropathol Exp Neurol 2006; 65: 305-318.
6. Richert ND, Ostuni JL, Bash CN, et al. Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b. AJNR Am J Neuroradiol 1998; 19: 1705-1713.
7. Inglese M, van Waesberghe JH, Rovaris M, et al. The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS. Neurology 2003; 60: 853-860.
8. Allen IV, McQuaid S, Mirakhur M, Nevin G,. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis [review]. Neurol Sci 2001; 22: 141-144.
9. Evangelou N, Konz D, Esiri MM, et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 2000; 123 (pt 9): 1845-1849.
10. Evangelou N, Konz D, Esiri MM, et al. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 2001; 124 (pt 9): 1813-1820.
11. Filippi M, Paty DW, Kappos L, et al. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 1995; 45: 255-260.
12. Rovaris M, Bozzali M, Santuccio G, et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 2001; 124 (pt 12): 2540-2549.
13. McFarland HF, Barkhof F, Antel J, Miller DH,. The role of MRI as a surrogate outcome measure in multiple sclerosis. Mult Scler 2002; 8: 40-51.
14. Bar-Zohar D, Agosta F, Goldstaub D, Filippi M,. Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives [review]. Mult Scler 2008; 14: 719-727.
15. Miller DH, Thompson AJ, Filippi M,. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis [review]. J Neurol 2003; 250: 1407-1419.
16. Ciccarelli O, Werring DJ, Barker GJ, et al. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging-evidence of Wallerian degeneration. J Neurol 2003; 250: 287-292.
17. Ge Y, Grossman RI, Babb JS, et al. Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. AJNR Am J Neuroradiol 2003; 24: 1935-1940.
18. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995; 45 (3 pt 1): 478-482.
19. Davie CA, Barker GJ, Thompson AJ, et al. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997; 63: 736-742.
20. Droogan AG, Clark CA, Werring DJ, et al. Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. Magn Reson Imaging 1999; 17: 653-661.
21. Stevenson VL, Parker GJ, Barker GJ, et al. Variations in T1 and T2 relaxation times of normal appearing white matter and lesions in multiple sclerosis. J Neurol Sci 2000; 178: 81-87.
22. Leary SM, Silver NC, Stevenson VL, et al. Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis. Mult Scler 1999; 5: 313-316.
23. van Buchem MA, McGowan JC, Kolson DL, et al. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996; 36: 632-636.
24. Traboulsee A, Dehmeshki J, Peters KR, et al. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities. Mult Scler 2003; 9: 566-573.
25. Agosta F, Rovaris M, Pagani E, et al. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006; 129 (pt 10): 2620-2627.
26. Dousset V, Brochet B, Vital A, et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol 1995; 16: 225-231.
27. Brochet B, Dousset V,. Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis [review]. Neurology 1999; 53 (5 suppl 3): S12-S17.
28. Barkhof F, Bruck W, De Groot CJ, et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 2003; 60: 1073-1081.
29. Schmierer K, Scaravilli F, Altmann DR, et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004; 56: 407-415.
30. Filippi M, Rocca MA, Martino G, et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998; 43: 809-814.
31. Vrenken H, Geurts JJ, Knol DL, et al. Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. AJNR Am J Neuroradiol 2006; 27: 2005-2011.
32. Fisher E, Chang A, Fox RJ, et al. Imaging correlates of axonal swelling in chronic multiple sclerosis brains. Ann Neurol 2007; 62: 219-228.
33. Moll NM, Cossoy MB, Fisher E, et al. Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. Arch Neurol 2009; 66: 44-53.
34. Young EA, Fowler CD, Kidd GJ, et al. Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions. Ann Neurol 2008; 63: 428-435.
35. Fisher E, Cothren RM, Tkach JA, et al. Knowledge-based 3D segmentation of MR images for quantitative MS lesion tracking. SPIE Med Imaging 1997; 3034: 19-25.
36. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285.
37. Lovas G, Szilagyi N, Majtenyi K, et al. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000; 123 (pt 2): 308-317.
38. Seewann A, Vrenken H, van der Valk P, et al. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch Neurol 2009; 66: 601-609.
39. Wayne Moore GR,. MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS? J Neurol Sci 2003; 206: 175-179.
40. Vos CM, Geurts JJ, Montagne L, et al. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis 2005; 20: 953-960.
41. Song SK, Yoshino J, Le TQ, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005; 26: 132-140.
42. Song SK, Sun SW, Ju WK, et al. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003; 20: 1714-1722.
43. Budde MD, Kim JH, Liang HF, et al. Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magn Reson Med 2007; 57: 688-695.
44. Sun SW, Liang HF, Le TQ, et al. Differential sensitivity of in vivo and ex vivo diffusion tensor imaging to evolving optic nerve injury in mice with retinal ischemia. Neuroimage 2006; 32: 1195-1204.
45. Schmierer K, Wheeler-Kingshott CA, Boulby PA, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 2007; 35: 467-477.
46. Schmierer K, Wheeler-Kingshott CA, Tozer DJ, et al. Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation. Magn Reson Med 2008; 59: 268-277.
47. Bö L, Geurts JJ, van der Valk P, et al. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 2007; 64: 76-80.
48. De Stefano N, Matthews PM, Filippi M, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003; 60: 1157-1162.